Angiopoietin-related Protein 4

Cefalù AB et al. () Identification of a novel LMF1 nonsense mutation responsible for severe hypertriglyceridemia by targeted next-generation sequencing.

Zheng J et al. (2012) Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development.

Romeo S et al. (2009) Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans.

Dewey FE et al. (2016) Inactivating Variants in ANGPTL4 and Risk of Coronary Artery Disease.

Kersten S et al. (2000) Characterization of the fasting-induced adipose factor FIAF, a novel peroxisome proliferator-activated receptor target gene.

Yoon JC et al. (2000) Peroxisome proliferator-activated receptor gamma target gene encoding a novel angiopoietin-related protein associated with adipose differentiation.

Bäckhed F et al. (2004) The gut microbiota as an environmental factor that regulates fat storage.

Minn AJ et al. (2005) Genes that mediate breast cancer metastasis to lung.

Sukonina V et al. (2006) Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue.

Galaup A et al. (2006) Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness.

Romeo S et al. (2007) Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL.

Padua D et al. (2008) TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4.

Talmud PJ et al. (2008) ANGPTL4 E40K and T266M: effects on plasma triglyceride and HDL levels, postprandial responses, and CHD risk.

Yin W et al. (2009) Genetic variation in ANGPTL4 provides insights into protein processing and function.

NCBI article

OMIM.ORG article